Concepedia

Harvey Schneier

HS

Statistics

Publications

11

Citations

1.4K

H-Index

11

Active since

2010

Affiliations

Harvard University(Current)

Case Western Reserve University

University of Michigan

Ironwood Pharmaceuticals (United States)

University of Colorado Denver

Harvey Schneier is an author at Harvard University specializing in medicine, pharmacotherapy, and clinical pharmacology.

Publications per year

2010–2020

11

Publications

11

Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety

William D. Chey, Anthony Lembo, Bernard J. Lavins et al. · The American Journal of Gastroenterology · 2012 · 451 citations

, , +15

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

Satish S.C. Rao, Anthony Lembo, Steven J. Shiff et al. · The American Journal of Gastroenterology · 2012 · 377 citations · Full text

, , +16

Two Randomized Trials of Linaclotide for Chronic Constipation

Anthony Lembo, Harvey Schneier, Steven J. Shiff et al. · New England Journal of Medicine · 2011 · 372 citations · Full text

, , +17

Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Deborah J. Wexler, Heidi Krause‐Steinrauf, Jill P. Crandall et al. · Diabetes Care · 2019 · 45 citations · Full text

, , +17

Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight

William I. Sivitz, Lawrence S. Phillips, Deborah J. Wexler et al. · Diabetes Care · 2020 · 26 citations · Full text

, , +17

1–5 of 11